Itraconazole in pharma franchise in Manipur

Itraconazole in PCD pharma franchise in Jaipur

Itraconazole in top pharma company in Amritsar

Itraconazole in pcd pharma supplier in Howrah

Itraconazole in phama franchise company in India
Itraconazole in phama distributor in Vijayawada

Home/Products /itraconazole-400mg-tablet

Italom 400 SR Tablet

Composition : Itraconazole (400mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10x1x4

Price : ₹80/-

Italom 400 SR Tablet contains Itraconazole (400 mg), a broad-spectrum antifungal medication belonging to the azole class. It is designed as a sustained-release (SR) formulation to provide a controlled and prolonged therapeutic effect, ensuring consistent efficacy against various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to the disruption of fungal growth and replication.

This medication is particularly effective against systemic and localized fungal infections caused by susceptible fungi, including infections of the skin, nails, mouth, throat, lungs, and other organs. Its broad antifungal spectrum covers dermatophytes, yeasts, and molds, making it a versatile option for treating complex and recurrent fungal conditions.

The sustained-release design of Itralom 400 SR Tablet enhances patient convenience by reducing the frequency of dosing, which promotes better adherence to the prescribed treatment regimen. This feature is particularly beneficial in the management of chronic or long-term fungal infections.

Read More

About the Product

Italom 400 SR Tablet contains Itraconazole (400 mg), a broad-spectrum antifungal medication belonging to the azole class. It is designed as a sustained-release (SR) formulation to provide a controlled and prolonged therapeutic effect, ensuring consistent efficacy against various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to the disruption of fungal growth and replication.

This medication is particularly effective against systemic and localized fungal infections caused by susceptible fungi, including infections of the skin, nails, mouth, throat, lungs, and other organs. Its broad antifungal spectrum covers dermatophytes, yeasts, and molds, making it a versatile option for treating complex and recurrent fungal conditions.

The sustained-release design of Itralom 400 SR Tablet enhances patient convenience by reducing the frequency of dosing, which promotes better adherence to the prescribed treatment regimen. This feature is particularly beneficial in the management of chronic or long-term fungal infections.

Common side effects may include nausea, abdominal discomfort, headache, and dizziness. Rarely, it may cause elevated liver enzymes or allergic reactions.

Italom 400 SR Tablet is indicated for the treatment of systemic and localized fungal infections, including aspergillosis, candidiasis, histoplasmosis, and onychomycosis.

Use only as directed by a healthcare provider. Avoid alcohol during treatment. Regular liver function monitoring is recommended for long-term use.

Store in a cool, dry place at a temperature below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation